Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 132 (1-2) , 112-120
Abstract
No abstract availableKeywords
Funding Information
- Sixth Framework Programme
- European Commission (115008)
- European Commission (LSHB-CT-2003-503428)
This publication has 44 references indexed in Scilit:
- Personalized Medicine for Depression: Can We Match Patients With Treatments?American Journal of Psychiatry, 2010
- Body weight as a predictor of antidepressant efficacy in the GENDEP projectJournal of Affective Disorders, 2009
- Trajectories of change in depression severity during treatment with antidepressantsPsychological Medicine, 2009
- DSM-IV Depression with Atypical Features: Is It Valid?Neuropsychopharmacology, 2009
- Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorderPsychiatry Research, 2009
- Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta‐analysisInternational Journal of Geriatric Psychiatry, 2009
- Measuring depression: comparison and integration of three scales in the GENDEP studyPsychological Medicine, 2007
- Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptylineDepression and Anxiety, 2004
- Do Age of Onset and Course of Illness Predict Different Treatment Outcome among DSM IV Depressive Disorders with Atypical Features?Neuropsychopharmacology, 2002
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979